EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review

B Andriambelo, M Stiffel, K Roke, M Plourde

Ageing Research Reviews · 2023-03 · 85 · 101835

DOI: 10.1016/j.arr.2022.101835 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Ageing Research Reviews, 2023-03. Verfasst von B Andriambelo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada, Centre de Recherche sur le Vieillissement, CIUSSS …. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long chain polyunsaturated omega-3 fatty acids (n-3 FA), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to be important components in a healthy diet and contribute to healthy functioning of the heart and the brain, among other organs. Although there are epidemiological studies on the strong relationship between fish or n-3 FA consumption and lower risk of cognitive decline, results from randomized controlled trials (RCTs) are less consistent. Here, we performed a scoping review on RCTs with n-3 FA supplementation where cognition was evaluated. Seventy-eight RCTs published before April 2022 were included in this review. Among these RCTs, 43.6% reported a positive cognitive outcome after the consumption of n-3 FA compared to the placebo. However, there was a large diversity of populations studied (age ranges and health status), wide range of doses of EPA + DHA supplemented (79 mg/day - 5200 mg/day) and a multitude of tests evaluating cognition, mainly diagnostic tests, that were used to assess cognitive scores and overall cognitive status. RCTs were thereafter categorized into non-cognitively impaired middle-aged adults (n = 24), non-cognitively impaired older adults (n = 24), adults with subjective memory complaints (n = 14), adults with mild cognitive impairments (MCI, n = 9) and people with diagnosed dementia or other cognitive changes (n = 7). Among these categories, 66.7% of RCTs conducted with MCI adults reported a positive cognitive outcome when supplemented with n-3 FA vs. the placebo. Therefore, this scoping review provides rationale and questions to a) strengthen the design of future RCTs with n-3 FA for cognitive outcomes, and b) generate more informative data to support clinicians in their practice in assessing cognition before and after a nutritional intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3AnimalsHumansRandomized Controlled Trials as TopicDocosahexaenoic AcidsEicosapentaenoic AcidDietary SupplementsCognition

Stichwörter der Autor:innen

Cognitive batteryDementiaMild cognitive impairmentsOmega-3 supplementationPlacebo, cognitionRandomized controlled trials

Substanzen

Fatty Acids, Omega-3Docosahexaenoic AcidsEicosapentaenoic Acid

Autor:innen und Institutionen

  • Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada, Centre de Recherche sur le Vieillissement, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada; Institut de la nutrition et…
  • GOED- Global Organization for EPA and DHA Omega-3, Salt Lake City, UT, United States.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Andriambelo, B., Stiffel, M., Roke, K., & Plourde, M. (2023). New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review. Ageing Research Reviews, 85, 101835. https://doi.org/10.1016/j.arr.2022.101835

Vancouver

Andriambelo B, Stiffel M, Roke K, Plourde M. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review. Ageing Research Reviews. 2023;85:101835. doi:10.1016/j.arr.2022.101835

BibTeX
@article{Andriambelo2023,
  author = {Andriambelo, B and Stiffel, M and Roke, K and Plourde, M},
  title = {New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review},
  journal = {Ageing Research Reviews},
  year = {2023},
  volume = {85},
  pages = {101835},
  doi = {10.1016/j.arr.2022.101835}
}
Kostenlos starten →